A Diabetes RELIEF Initiative: Realizing the Potential of GLP-1 Receptor Agonists in Type 2 Diabetes: Partnering with Patients to Improve Glycemic and Cardiovascular Outcomes
Podcast 6: A Patient’s Journey with Type 2 Diabetes
Post-Test/Evaluation
Questions marked with a
*
are required
59%
Contact Information
First Name
Last Name
Email Address
Credentials/Degree (MD, DO, RN, etc.)
Date of Participation
Month
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Day
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Year
2018
2019
2020
2021
2022
2023
2024
2025
Which of the following strategies would NOT enhance the patient provider partnership when managing patients with T2DM and assist with shared decision regarding selection of a GLP-1 receptor agonist?
A. Counsel patients on treatment benefits that include weight loss, quality of life, cardiovascular benefits, and increased satiety
B. Prepare for first injection in office and titrate slowly based on prescribing information
C. Provide access to resources and education, including a diabetes educator and/or nutritionist
D. Proactively discuss that the patient’s BMI is higher than it should be and recommend a GLP-1 receptor agonist to target glucose control and weight loss
What is your specialty focus?
Endocrinology
Family Practice
Internal Medicine
Nurse Practitioner
Nurse
Pharmacist
Physician Assistant
Other
What is your type of practice?
Community/Private
Clinic
Academic
Hospital
HMO/MCO
Other
How many years have you been in practice?
Fewer than 5
5 to 9
10 to 15
More than 15
N/A
Please estimate the number of patients with type 2 diabetes that you treat each month:
1-10
11-25
26-50
51-75
> 75
N/A
Were the following learning objectives met?
Please check appropriate rating
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Describe strategies for enhancing the patient/provider partnership when managing patients with T2DM
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Implement a shared decision-making approach to the selection of GLP-1 receptor agonists
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Please rate your confidence in your ability to evaluate, diagnose, and manage patients with type 2 diabetes
on a scale of 1 to 5, where 1 means "not confident at all, and 5 means "very confident."
Confidence
1
2
3
4
5
As a result of this course, I will likely make changes to my practice.
Yes
No
N/A
If YES, in which of the following categories?
(Please check all that apply)
Diagnosis
Treatment Approach
Patient Safety
Coordination of Care
Patient Communication/Patient Education
In particular, as a result of this course, I will be more likely to implement the following changes:
(Please check all that apply)
Incorporate the patient in the decision-making process when selecting GLP-1 receptor agonists
Enhance my partnership with patients with T2DM in their management
Additionally, I will change:
Start
Powered by
QuestionPro
Loading...
close
drag_indicator
close
Yes
Cancel
Continue
Answer Question
Continue Without Answering
Keep Data
Discard
close